Click on the paperclip at the top of the page to add, remove or edit files. If possible, please add a row to the table below to allow easy access to your slides.
Meeting date |
Uploaded by |
Slides |
Comments |
|---|---|---|---|
2 May 2012 |
Julie |
PFIM Interface 3.1 - cours M2R 10-11.pdf |
|
15 May 2012 |
Angelina |
|
|
6 June 2012 |
Joe |
|
|
13 June 2012 |
Joanna |
EMA geriatric workshop - March 2012 - Shepard (submitted 19March).ppt |
Terry Shepard's Slides |
12 October 2012 |
Rollo |
|
|
9 November 2012 |
Joanna |
|
|
13 November 2012 |
Julie |
|
|
14 December 2012 |
Lilia |
Modelling neutrophil dynamics in children following bone marrow transplant |
|
22 Februrary 2013 |
Allienor Berges |
|
|
1 March 2013 |
Rollo |
|
|
28 May 2013 |
Charlotte |
|
List of past meetings:
9 May 2012 |
PUW1 |
Joanna |
Immunology |
16 May 2012 |
WCJ |
Angelina |
Zidovudine PK/PG |
23 May 2012 |
PUW2 |
Jig |
LMWH in pregnancy |
30 May 2012 |
No meeting |
|
|
6 June 2012 |
PUW1 |
Joe |
Antimicrobial PKPD |
13 June 2012 |
PUW1 |
Terry Shepard |
Geriatric PKPD |
20 June 2012 |
PUW2 |
Rollo/Joanna |
Immunology modelling |
27 June 2012 |
No meeting |
|
|
4th July 2012 |
No meeting |
|
|
11th July 2012 |
PUW2 |
Julie |
PAGE review |
18th July 2012 |
PUW2 |
Katie |
Gentamicin in burns |
12/10/12 1pm |
WCA |
Rollo |
Modelling of the immune reconstitution post BMT |
19/10/12 1pm |
PUW3 |
Joe |
Prague Biometrics 2012;68:902-11 |
26/10/12 1pm |
PUW3 |
Charlotte |
NAPPA (Beta lactam pharmacokinetics/pharmacodynamics) plans |
2/11/12 1pm |
PUW3 |
Eva |
Neogent (developing Bayesian therapeutic drug monitoring) progress |
9/11/12 1pm |
PUW3 |
Joanna |
Inference methods course review |
16/11/12 1pm |
PUW2 |
|
General discussion |
23/11/12 1pm |
PUW3 |
Julie |
Covariate selection methods in pharmacokinetic modelling |
30/11/12 1pm |
PUW3 |
Julie |
NCA versus modelling in phase I studies for drugs with long half-life |
7/12/12 1pm |
PUW3 |
|
Goldacre talk |
14/12/12 1pm |
PUW3 |
Lilia |
Neutropenia post-BMT |
4/1/13 1pm |
PUW3 |
|
General discussion |
11/1/13 1pm |
Levinsky |
Joe |
Maraviroc PK |
18/1/13 1pm |
PUW4 |
Andrezj |
PKPD bridging of response between adults and children |
25/1/13 1pm |
PUW3 |
Lilia |
Neutropenia following paediatric BMT |
1/2/13 1pm |
PUW1 |
Mirjam Trame |
Use of PKPD modeling to guide HIV understanding and treatment |
8/2/13 1pm |
PUW3 |
Sami |
Bioequivalence studies and genetic variability |
15/2/13 1pm |
PUW1 |
Liana |
ErbB inhibition for PKD |
22/2/13 1pm |
PUW3 |
Alienor Berges (GSK) |
|
1/3/13 1pm |
PUW4 |
Rollo |
CD4 reconstitution post BMT |
8/3/13 1pm |
PUW3 |
Eva |
Neogent update |
15/3/13 1pm |
PUW4 |
Tafi |
Dose individualisation in HIV/AIDS and TB patients on Efavirenz (EFV). |
22/3/13 1pm |
PUW3 |
Hui Ma |
Genetic components to glucose-insulin response |
26/4/13 1pm |
PUW3 |
Sarit |
FA and bioavailability |
10/5/13 1pm |
PUW3 |
Tafi |
Common adverse drug reactions linked to HIV and/or TB medication: Lipodystrophy, Skin Hypersensitivity, CNS and Peripheral Neuropathy. |
28/5/13 1pm |
PUW1 |
Charlotte |
Use of meta-analysis in evidence synthesis: an example based on dose selection for antibiotics (PAGE talk) |
31/5/13 1pm |
PUW1 |
Rollo |
Modelling immune reconstitution in children post HSCT (PAGE talk) |
7/6/13 1pm |
PUW3 |
Julie |
Penalized regression implementation within the SAEM algorithm to advance high-throughput personalized drug therapy (PAGE talk) |
21/6/13 1pm |
PUW1 |
Bruce Green |
Therapeutic Drug Monitoring |
16/9/13 1pm |
PUW3 |
Joe |
Diagnostics for bivariate regression models |
23/9/13 1pm |
PUW3 |
No meeting |
Julie Seminar on Tues 24/9. |
30/9/13 1pm |
PUW2 |
Jan-Stefan Van der Walt |
Nonlinear mixed effects model for saliva cortisol and cortisone in patients with Addisons disease and healthy volunteers. |
1/10/13 1pm EXTRA MEETING |
PUW4 |
Stefanie Hennig |
Changes in between subject variability with covariate models in pharmacometrics |
7/10/13 1pm |
PUW2 |
|
|
14/10/13 1pm |
PUW3 |
Tafi |
TBA |
21/10/13 1pm |
PUW2 |
Julie |
Modelling of tenofovir and emtricitabine PK in the ANRS 134-COPHAR 3 trial (work in progress) |
28/10/13 1pm |
PUW3 |
Joanna |
CD4 recovery in the CHER study |
4/11/13 1pm |
PUW2 |
Eva |
Upgrade talk practice |
11/11/13 1pm |
PUW3 |
Flora Musuamba |
Use of modelling and simulation tools to improve decision-making in drug development and clinical practice |
18/11/13 1pm |
PUW2 |
Joe |
Decision theory and antimicrobials |
25/11/13 1pm |
PUW3 |
Andreas |
Pain PKPD |
2/12/13 1pm |
TWC F |
No meeting |
|
9/12/13 1pm |
PUW3 |
Pieter de Cock |
Paediatric antimicrobial PKPD in ICU |
16/12/13 1pm |
PUW3 |
Rollo |
Modelling TCR repertoire (not with NLME!) |
20/1/14 |
PUW3 |
Jessica Soto |
Modelling taste studies |
27/1/14 |
PUW1 |
Joanna |
Practice for South Africa |
3/2/14 |
PUW3 |
Liana |
PK of tyrosine kinase inhibitors in PKD animal model |
10/2/14 |
PUW4 |
Eva |
Neogent predictions |
17/2/14 |
PUW3 |
Deji |
Hepatitis and HIV co-infection modelling |
24/2/14 |
PUW1 |
|
|
3/3/14 |
PUW2 |
Rollo |
Upgrade practice |
10/3/14 |
PUW1 |
Joe |
Clonidine PKPD for sedation in PICU |
17/3/14 |
PUW3 |
Andreas |
Clinical protocol development for GAbapentine in Paediatric pain Project : Optimization of the trial design characteristics based on (E)D optimality using popED. |
24/3/14 |
PUW3 |
Julie |
MRC Biostats talk on new methods for genetic covariates in PKPD modelling. |
31/3/14 |
PUW1 |
Flora |
Clinical protocol development for GAbapentine in Paediatric Pain Project : Dose rationale and dosing schedule for characterisation efficacy in chronic pain |
7/4/14 |
PUW3 |
Morris |
Development and dose rationale for fixed dose combinations for the treatment of tuberculosis |
14/4/14 |
WCD |
Andrezj |
Population Pharmacokinetic Analysis of Efavirenz in African Children using mixture modelling to describe clearance multimodality |
26/4/14 |
PUW4 |
|
|
12/5/14 |
PUW2 |
Carlos Hoyo |
Nifedipine PKPD |
19/5/14 |
WCC |
Gavin Jarvis |
A Modelling Approach to the Genetics of Embryonic Growth |
23/6/14 |
PUW3 |
All |
PAGE meeting review |
30/6/14 |
PUW2 |
Flora |
NLME cluster demonstration |
7/7/14 |
PUW1 |
Sophie Rhodes |
The immune response to BCG vaccination over time and the population variation of immune response dynamics |
14/7/14 |
PUW2 |
Joanna and Jamie |
An ODE model of peptide presentation by MHC-I / Geometric MCMC |
|
|
|
SUMMER |